Recruiting

Neural Bypass System

Sponsor:

Chad Bouton

Code:

NCT03680872

Conditions

Spinal Cord Injuries

Spinal Cord Injury Cervical

Eligibility Criteria

Sex: All

Age: 22 - 65

Healthy Volunteers: Not accepted

Interventions

Bidirectional Neural Bypass System

Study Details

Brief summary:

This is a single-cohort early feasibility trial to determine whether an investigational device called the Bidirectional Neural Bypass System can lead to the restoration of movement and sensation in the hand and wrist of up to seven individuals with tetraplegia.

Conditions

Spinal Cord Injuries

Spinal Cord Injury Cervical

Study ID

NCT03680872

Start date

Sep 30, 2019

Status verified date

Jun, 2025

Completion date

Dec, 2028

Anticipated

Primary completion date

Dec, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 22 - 65

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Males and females between 22 and 65 years of age
2. Individuals with a stable cervical spinal cord injury that have International Standards for the Neurological Classification of SCI (ISNCSCI) motor scores for fingers of 0 - 2 (non-functional) and ISNCSCI sensory scores of 0 - 2 (not normal) on the palmar side
3. Individuals at least one year from initial spinal cord injury
4. Individuals that are considered English Proficient due to the study requirements to follow verbal commands during testing sessions
5. Individuals that are able to comprehend the study goals and procedures, and are able to provide informed consent for participation.
6. Individuals that are willing and able to visit the study center for study procedures that will be 1-3 sessions a week for up to 48 months at 1-4 hours per session.
7. Have the ability and willingness to undergo upper limb electrodiagnostic and nerve conduction studies
8. Demonstrate typical amplitude, latency, and conduction velocity in the distal median, ulnar, and radial nerves of at least one upper limb

Exclusion Criteria:

1. Individuals participating in another research study that may affect the conduct or results of this study
2. Individuals having or exhibiting any of the following:

1. Medical contraindications for diffusion tensor imaging, functional magnetic resonance imaging, electromyography, computed tomography, cortical stimulation, or craniotomies/surgeries
2. Prior difficulties or allergy to general anesthesia
3. Active wound healing or skin breakdown issues
4. Stage III-IV pressure ulcers
5. Chronically-implanted electronic medical device (e.g. baclofen pump, deep brain stimulator, epidural stimulator, cardiac pacemaker, vagus nerve stimulator, or other)
6. Prior tendon transfer to enhance hand function
7. History of autoimmune disease
8. Cancer
9. Biochemical abnormalities of the liver, kidney, or pancreas
10. Ventilator dependence
11. History of serious mood or thought disorder
12. Significant residual clinically evident traumatic brain injury or cognitive impairment
13. Uncontrolled autonomic dysreflexia
14. Spasticity in the upper extremities that is uncontrolled by pharmacological methods
15. Diagnosis of acute myocardial infarction or cardiac arrest within previous 6 months
16. Individuals with any type of destruction and/or damage to the motor cortex region as determined by fMRI.
17. History of a neurological ablation procedure
18. History of hemorrhagic stroke
19. History of infectious or chronic diseases, such as HIV or tuberculosis
3. Individuals with any of the following co-morbid conditions that would interfere with study activities or response to treatment:

1. Life expectancy < 3 years
2. Severe chronic pulmonary disease
3. Intractable seizure disorders
4. Local, systemic acute or chronic infectious illness
5. Life threatening cardiac arrhythmias
6. Severe collagen vascular disorder
7. Kidney failure or other major organ systems failures
4. Individuals with a substance abuse (alcoholism or other) problem
5. Pregnant women
6. Prisoners

Study Design

Enrollment

7 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Spinal Cord Injury Participants

This group consists of individuals with tetraplegia receiving an investigational device called the Bidirectional Neural Bypass System.

Interventions

Bidirectional Neural Bypass System

These participants will receive the investigational device called the Bidirectional Neural Bypass System. The study intends to use this device to restore volitional movement and sensation to the hand and wrist of an individual during its use in the laboratory.

Primary outcome measure

  • Restoration of Movement [ Time Frame: The primary outcome will be assessed over the course of 48 months during the study's restoration sessions. ]
  • Restoration of Sensation [ Time Frame: The primary outcome will be assessed over the course of 48 months during the study's restoration sessions. ]

Central Contacts and Locations

Central contacts

Locations

Northwell Health's The Feinstein Institute for Medical Research

Recruiting

Manhasset, New York, United States, 11030

Contacts

Principal Investigator:

Chad E Bouton

More Information

Sponsor

Chad Bouton

Last update posted

Mar 11, 2026

Last verified

Jun, 2025

Keywords

  • Physical and Rehabilitation Medicine
  • Biomedical Engineering
  • Paralysis
  • Tetraplegia
  • Quadriplegia
  • Movement Restoration
  • Muscle Stimulation
  • Tactile Sensation
  • Spinal Cord Stimulation

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Chad Bouton on 2026-03-11.